Detection of serum tumor markers in multiple myeloma using the CLINPROT system

International Journal of Hematology

Volumn 95, Issue 6, 2012, Pages 668-674

  He, Aili ^a   Bai, Ju ^a   Huang, Chen ^a   Yang, Juan ^a   Zhang, Wanggang ^a   Wang, Jianli ^a   Yang, Yun ^a   Zhang, Pengyu ^a   Zhou, Fuling ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Biomarker; Diagnostic model; Magnetic beads; Multiple myeloma; Serum proteomics

Indexed keywords

TUMOR MARKER;

ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CATION EXCHANGE; CLINICAL ARTICLE; CLINPROT SYSTEM; CONTROLLED STUDY; FEMALE; HUMAN; MAGNET; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MULTIPLE MYELOMA; PROTEOMICS; SENSITIVITY AND SPECIFICITY; SIGNAL NOISE RATIO;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NEURAL NETWORKS (COMPUTER); PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 84865038600     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-012-1080-3     Document Type: Article

References (26)

1. San Miguel JF, Gutierrez NC, Mateo G, Orfao A. Conventional diagnostics in multiple myeloma. Eur J Cancer. 2006;42:1510-9. (Pubitemid 44118776)
2. International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol. 2003;121:749-57.
3. Hussein MA, Juturi JV, Lieberman I. Multiple myeloma: present and future. Curr Opin Oncol. 2002;14:31-5. (Pubitemid 34072960)
4. Sirohi B, Powles R. Multiple myeloma. Lancet. 2004;363:875-87.
5. Bataille R, Harousseau JL. Multiple myeloma. N Engl J Med. 1997;336:1657-64.
6. Hideshima T, Chauhan D, Shima Y, Raje N, Davies FE, et al. Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy. Blood. 2000;96: 2943-50.
7. Grosbois B, Decaux O, Azais I, Facon T, Avet-Loiseau H. Current treatment strategies for multiple myeloma. Eur J Intern Med. 2002;13:85-95. (Pubitemid 34226703)
8. Bergsagel PL, Kuehl WM. Molecular pathogenesis and a consequent classification of multiple myeloma. J Clin Oncol. 2005; 23:6333-8. (Pubitemid 46218843)
9. Dingli D, Pacheco JM, Nowakowski GS, Kumar SK, Dispenzieri A, et al. Relationship between depth of response and outcome in multiple myeloma. J Clin Oncol. 2007;25:4933-7. (Pubitemid 350220425)
10. Kumar SK, Rajkumar SV, Dispenzieri A, Lacy MQ, Hayman SR, et al. Improved survival in multiple myeloma and the impact of novel therapies. Blood. 2008;111:2516-20.
11. Brenner H, Gondos A, Pulte D. Recent major improvement in long-term survival of younger patients with multiple myeloma. Blood. 2008;111:2521-6.
12. Cavo M, Terragna C, Renzulli M, Zamagni E, Tosi P, et al. Poor outcome with front-line autologous transplantation in t(4;14) multiple myeloma: low complete remission rate and short duration of remission. J Clin Oncol. 2006;24:e4-5.
13. Blade J, Rosinol L, Sureda A, Ribera JM, Diaz-Mediavilla J, et al. High-dose therapy intensification compared with continued standard chemotherapy in multiple myeloma patients responding to the initial chemotherapy: long-term results from a prospective randomized trial from the Spanish cooperative group PETHEMA. Blood. 2005;106:3755-9. (Pubitemid 41739009)
14. Fermand JP, Katsahian S, Divine M, Leblond V, Dreyfus F, et al. High-dose therapy and autologous blood stem-cell transplantation compared with conventional treatment in myeloma patients aged 55 to 65 years: long-term results of a randomized control trial from the Group Myelome-Autogreffe. J Clin Oncol. 2005;23: 9227-33.
15. Wang QT, Li YZ, Liang YF, Hu CJ, Zhai YH, et al. Construction of A Multiple Myeloma Diagnostic Model by Magnetic Bead- Based MALDI-TOF Mass Spectrometry of Serum and Pattern Recognition Software. Anat Rec Adv Integr Anat Evol Biol. 2009;292:604-10.
16. Baumann S, Ceglarek U, Fiedler GM, Lembcke J, Leichtle A, et al. Standardized approach to proteome profiling of human serum based on magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chem. 2005;51:973-80. (Pubitemid 40740877)
17. Ketterlinus R, Hsieh SY, Teng SH, Lee H, Pusch W. Fishing for biomarkers: analyzing mass spectrometry data with the new ClinProTools software. Biotechniques. 2005;Suppl:37-40.
18. Villanueva J, Philip J, Entenberg D, Chaparro CA, Tanwar MK, et al. Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry. Anal Chem. 2004;76:1560-70. (Pubitemid 38338398)
19. Sogawa K, Satoh M, Kodera Y, Tomonaga T, Iyo M, et al. A search for novel markers of alcohol abuse using magnetic beads and MALDI-TOF/TOF mass spectrometry. Proteomics Clin Appl. 2009;3:821-8.
20. Ziganshin R, Alekseev DG, Arapidi GP, Ivanov VT, Moshkovskii SA, et al. Serum proteome profiling for ovarion cancer diagnosis using ClinProt magnetic bead technique and MALDI-TOF-massspectrometry. Biomed Khim. 2008;54:408-19.
21. Albitar M, Potts SJ, Giles FJ, O'Brien S, Keating M, et al. Proteomic- based prediction of clinical behavior in adult acute lymphoblastic leukemia. Cancer. 2006;106:1587-94.
22. Mohamedali A, Guinn BA, Sahu S, Thomas NS, Mufti GJ. Serum profiling reveals distinctive proteomic markers in chronic myeloid leukaemia patients. Br J Haematol. 2009;144:263-5.
23. Riley RD, Burchill SA, Abrams KR, Heney D, Sutton AJ, et al. A systematic review of molecular and biological markers in tumours of the Ewing's sarcoma family. Eur J Cancer. 2003;39: 19-30. (Pubitemid 36005421)
24. Duffy MJ. Role of tumor markers in patients with solid cancers: A critical review. Eur J Intern Med. 2007;18:175-84. (Pubitemid 46628757)
25. Gadducci A, Tana R, Cosio S, Genazzani AR. The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature. Crit Rev Oncol Hematol. 2008;66:10-20. (Pubitemid 351324130)
26. Bhattacharyya S, Epstein J, Suva LJ. Biomarkers that discriminate multiple myeloma patients with or without skeletal involvement detected using SELDI-TOF mass spectrometry and statistical and machine learning tools. Dis Markers. 2006;22: 245-55. (Pubitemid 44763277)